POSTN and gastric cancer: In advanced GC (n = 85), using an untargeted proteomic approach based on LC-MS/MS, Jin et al. [88] succeeded in identifying protein profiles associated with malignant versus benign ascites and found that two proteins (progastriscin or pepsinogen C, PGC; periostin, POSTN) may be candidate biomarkers of advanced disease.